PATENT CLAIM ANALYSIS

Application Number: 15747507
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "640000"]

Abstract:
The present invention relates to cationic compounds of formula (I) for use as peripheral NMDA receptor antagonists.

Claim (Index 8):
Cationic compound according to  claim 1 , wherein R 3 , R 4  and R 5  are simultaneously a methyl group.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14399945', '13129916', '15560265', '14738148', '15552997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7497420278879349
- 35 USC 102 Novelty (BERT): 0.5121041572671273
- Combined Prediction Score: 0.725978240825854
- Mean Citation Score: 264.37507200000005
- Max Citation Score: 271.68488
- Similarity Product: 206.70961440444947

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test